CHOLESTYRAMINE IN TYPE-II HYPERLIPOPROTEINEMIA - DOUBLE-BLIND TRIAL

被引：117

作者：

LEVY, RI ^{[1
]}

FREDRICKSON, DS ^{[1
]}

STONE, NJ ^{[1
]}

BILHEIMER, DW ^{[1
]}

BROWN, WV ^{[1
]}

GLUECK, CJ ^{[1
]}

GOTTO, AM ^{[1
]}

HERBERT, PN ^{[1
]}

KWITEROVICH, PO ^{[1
]}

LANGER, T ^{[1
]}

LAROSA, J ^{[1
]}

LUX, SE ^{[1
]}

RIDER, AK ^{[1
]}

SHULMAN, RS ^{[1
]}

SLOAN, HR ^{[1
]}

机构：

[1] NHLI, MOLEC DIS BRANCH, BETHESDA, MD 20014 USA

来源：

ANNALS OF INTERNAL MEDICINE | 1973年 / 79卷 / 01期

关键词：

D O I：

10.7326/0003-4819-79-1-51

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：51 / 58

页数：8

共 50 条

[21] TREATMENT OF FAMILIAL TYPE-II HYPERLIPOPROTEINEMIA [J].

CASDORPH, HR .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1976, 235 (17) :1903-1903

[22] FIBRINOLYTIC INHIBITOR IN TYPE-II HYPERLIPOPROTEINEMIA [J].

BROMMER, EJP ;

LEUVEN, JAG ;

KLUFT, C ;

WIJNGAARDS, G .

LANCET, 1982, 1 (8280) :1066-1066

[23] SECHOLEX AND CLOFIBRATE IN TYPE-II HYPERLIPOPROTEINEMIA [J].

HOWARD, AN ;

EVANS, RJC .

MEDIKON, 1977, 6 (08) :3-5

[24] SOYBEAN IN THE TREATMENT OF TYPE-II HYPERLIPOPROTEINEMIA [J].

NOSEDA, G ;

FRAGIACOMO, C ;

BOSIA, C ;

RAMELLI, F ;

SIRTORI, CR .

SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1979, 109 (47) :1852-1853

[25] COLESTIPOL IN FAMILIAL TYPE-II HYPERLIPOPROTEINEMIA - 3-YEAR TRIAL [J].

HARVENGT, C ;

DESAGER, JP .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1976, 20 (03) :310-314

[26] INHERITANCE OF MILD TYPE-II HYPERLIPOPROTEINEMIA [J].

BALLANTYNE, D ;

LAWRIE, TDV .

SCOTTISH MEDICAL JOURNAL, 1975, 20 (01) :23-26

[27] TREATMENT OF HYPERLIPOPROTEINEMIA TYPE-II WITH ETOFIBRATE [J].

GUSTAFSON, A .

INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND BIOPHARMACY, 1979, 17 (12) :498-502

[28] ENDOGENOUS HYPERTRIGLYCERIDEMIA IN TYPE-II HYPERLIPOPROTEINEMIA [J].

BLANKENH.DH ;

CHIN, HP ;

JENSEN, J .

AMERICAN JOURNAL OF HUMAN GENETICS, 1970, 22 (05) :493-&

[29] KYRLES DISEASE AND TYPE-II HYPERLIPOPROTEINEMIA [J].

TOMECKI, KJ ;

BATTAGLINI, JW ;

MAIZE, JC .

ARCHIVES OF DERMATOLOGY, 1980, 116 (02) :227-228

[30] HALOFENATE IN TREATMENT OF TYPE-2 HYPERLIPOPROTEINEMIA - DOUBLE-BLIND COMPARISON WITH CLOFIBRATE [J].

REES, ED ;

HAMILTON, RD ;

KANNER, IF ;

WASSON, S ;

HEARN, T .

ATHEROSCLEROSIS, 1976, 24 (03) :537-549

← 1 2 3 4 5 →